SARS-CoV-2 antibodies: Prospects for therapy, vaccines and return to work
April 17, 2020 | 7:30am - 9:00am ET
Livestreaming
Click this link to view the livestream recording.
| 7:30am |
Bruce Walker, MD Co-Faculty Chair, MassCPR/Ragon Institute of MGH, MIT and Harvard Introduction to MassCPR and Symposium Goals |
| 7:35am |
Michael Mina, MD, PhD MassCPR/Harvard TH Chan School of Public Health COVID-19 epidemiology and the role and limitations of PCR and serology |
| 7:42am |
Galit Alter, PhD MassCPR/Ragon Institute of MGH, MIT and Harvard Tools to define protective humoral responses to SARS-CoV-2 |
| 7:49am |
David Walt, PhD MassCPR/Wyss Institute for Biologically Inspired Engineering Development of an ultrasensitive single molecule seroconversion assay |
| 7:56am |
Linqi Zhang, PhD Tsinghua University Human neutralizing antibodies to SARS-CoV-2 |
| 8:03am |
Jincun Zhao, PhD Guangzhou Institute for Respiratory Health Kinetics of viral load, antibody responses and COVID-19 disease severity |
| 8:10am |
Megan Murray, MD, MPH, ScD MassCPR/Department of Global Health and Social Medicine, HMS Population Sero-surveillance studies |
| 8:17am | Q & A |
| 8:55am |
Arlene Sharpe Co-Faculty Chair, MassCPR/Evergrande Center for Immunologic Disease, HMS Closing comments |